首页> 美国卫生研究院文献>other >IL-1β-Mediated Activation of Adipose-Derived Mesenchymal Stromal Cells Results in PMN Reallocation and Enhanced Phagocytosis: A Possible Mechanism for the Reduction of Osteoarthritis Pathology
【2h】

IL-1β-Mediated Activation of Adipose-Derived Mesenchymal Stromal Cells Results in PMN Reallocation and Enhanced Phagocytosis: A Possible Mechanism for the Reduction of Osteoarthritis Pathology

机译:IL-1β介导的脂肪间充质基质细胞激活导致PMN重新分配和增强的吞噬作用:减少骨关节炎病理的可能机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Injection of adipose-derived mesenchymal stromal cells (ASCs) into murine knee joints after induction of inflammatory collagenase-induced osteoarthritis (CiOA) reduces development of joint pathology. This protection is only achieved when ASCs are applied in early CiOA, which is characterized by synovitis and high S100A8/A9 and IL-1β levels, suggesting that inflammation is a prerequisite for the protective effect of ASCs. Our objective was to gain more insight into the interplay between synovitis and ASC-mediated amelioration of CiOA pathology.>Methods: CiOA was induced by intra-articular collagenase injection. Knee joint sections were stained with hematoxylin/eosin and immunolocalization of polymorphonuclear cells (PMNs) and ASCs was performed using antibodies for NIMP-R14 and CD271, respectively. Chemokine expression induced by IL-1β or S100A8/A9 was assessed with qPCR and Luminex. ASC-PMN co-cultures were analyzed microscopically and with Luminex for inflammatory mediators. Migration of PMNs through transwell membranes toward conditioned medium of non-stimulated ASCs (ASCNS-CM) or IL-1β-stimulated ASCs (ASCIL-1β-CM) was examined using flow cytometry. Phagocytic capacity of PMNs was measured with labeled zymosan particles.>Results: Intra-articular saline injection on day 7 of CiOA increased synovitis after 6 h, characterized by PMNs scattered throughout the joint cavity and the synovium. ASC injection resulted in comparable numbers of PMNs which clustered around ASCs in close interaction with the synovial lining. IL-1β-stimulation of ASCs in vitro strongly increased expression of PMN-attracting chemokines CXCL5, CXCL7, and KC, whereas S100A8/A9-stimulation did not. In agreement, the number of clustered PMNs per ASC was significantly increased after 6 h of co-culturing with IL-1β-stimulated ASCs. Also migration of PMNs toward ASCIL-1β-CM was significantly enhanced (287%) when compared to ASCNS-CM. Interestingly, association of PMNs with ASCs significantly diminished KC protein release by ASCs (69% lower after 24 h), accompanied by reduced release of S100A8/A9 protein by the PMNs. Moreover, phagocytic capacity of PMNs was strongly enhanced after priming with ASCIL-1β-CM.>Conclusions: Local application of ASCs in inflamed CiOA knee joints results in clustering of attracted PMNs with ASCs in the synovium, which is likely mediated by IL-1β-induced up-regulation of chemokine release by ASCs. This results in enhanced phagocytic capacity of PMNs, enabling the clearance of debris to attenuate synovitis.
机译:>背景:炎症性胶原酶诱导的骨关节炎(CiOA)诱导后,将脂肪来源的间充质基质细胞(ASC)注入鼠膝关节可减少关节病理的发展。仅当在滑膜炎和高S100A8 / A9和IL-1β水平特征在于早期CiOA中应用ASC时,才能实现这种保护,这表明炎症是ASC保护作用的先决条件。我们的目的是更深入地了解滑膜炎与ASC介导的CiOA病理改善之间的相互作用。>方法:关节内胶原酶注射可诱导CiOA。膝关节切片用苏木精/曙红染色,并分别使用NIMP-R14和CD271抗体对多形核细胞(PMN)和ASC进行免疫定位。用qPCR和Luminex评估IL-1β或S100A8 / A9诱导的趋化因子表达。显微镜下分析ASC-PMN共培养物,并与Luminex一起分析炎症介质。使用流式细胞仪检查了PMN通过transwell膜向未刺激的ASC(ASCNS-CM)或IL-1β刺激的ASC(ASCIL-1β-CM)的条件培养基的迁移。用标记的酵母聚糖颗粒测量PMN的吞噬能力。>结果: CiOA的第7天关节腔内注射盐水在6 h后会增加滑膜炎,其特征是PMN散布在整个关节腔和滑膜中。 ASC注射导致相当数量的PMN聚集在ASC周围,并与滑膜衬层紧密相互作用。体外ASC的IL-1β刺激可大大增加PMN吸引趋化因子CXCL5,CXCL7和KC的表达,而S100A8 / A9刺激则不。一致的是,与IL-1β刺激的ASC共培养6小时后,每个ASC的PMN簇状数量明显增加。与ASCNS-CM相比,PMN向ASCIL-1β-CM的迁移也显着增强(287%)。有趣的是,PMN与ASC的结合显着减少了ASC的KC蛋白释放(24小时后降低了69%),并伴随着PMN减少了S100A8 / A9蛋白的释放。此外,在使用ASCIL-1β-CM引发后,PMN的吞噬能力得到了极大增强。可能是由IL-1β诱导ASCs趋化因子释放的上调所介导的。这样可以增强PMN的吞噬能力,​​从而清除碎片以减轻滑膜炎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号